Spots Global Cancer Trial Database for squamous cell carcinoma of the anus
Every month we try and update this database with for squamous cell carcinoma of the anus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | NCT00955240 | Anal Cancer | cetuximab cisplatin fluorouracil laboratory biom... radiation thera... | 18 Years - 80 Years | UNICANCER | |
| Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | NCT00423293 | Anal Cancer | fluorouracil mitomycin C Intensity-modul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | NCT00324415 | Anal Cancer | cetuximab cisplatin fluorouracil radiation thera... | 18 Years - 120 Years | AIDS Malignancy Consortium | |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | NCT00955240 | Anal Cancer | cetuximab cisplatin fluorouracil laboratory biom... radiation thera... | 18 Years - 80 Years | UNICANCER | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00003652 | Anal Cancer | cisplatin fluorouracil neoadjuvant the... radiation thera... | 0 Years - 80 Years | UNICANCER | |
| Molecular Biology of Anal Cancer in HIV-Positive Patients | NCT00952874 | Carcinoma HIV Infections | 20 Years - 80 Years | University Hospital, Geneva | ||
| International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel | NCT02051868 | Squamous Cell C... | Cisplatin 5-Fluorouracil ... Carboplatin Paclitaxel | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00003596 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | NCT00955240 | Anal Cancer | cetuximab cisplatin fluorouracil laboratory biom... radiation thera... | 18 Years - 80 Years | UNICANCER | |
| A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer | NCT02797964 | Advanced Solid ... | SRA737 | 18 Years - | Sierra Oncology LLC - a GSK company | |
| PEN-866 in Patients With Advanced Solid Malignancies | NCT03221400 | Carcinoma Endometrial Ade... Neoplasms Squamous Cell C... Adenocarcinoma ... Advanced Cancer Solid Tumor Solid Carcinoma Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Gastric Cancer Gastric Adenoca... Gastroesophagea... Small-cell Lung... Small Cell Lung... Pancreatic Duct... Pancreatic Aden... | PEN-866 Sodium fluorouracil Folinic acid Niraparib | 18 Years - | Tarveda Therapeutics | |
| Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | NCT00068744 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | NCT00324415 | Anal Cancer | cetuximab cisplatin fluorouracil radiation thera... | 18 Years - 120 Years | AIDS Malignancy Consortium | |
| International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel | NCT02051868 | Squamous Cell C... | Cisplatin 5-Fluorouracil ... Carboplatin Paclitaxel | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00093379 | Anal Cancer | Capecitabine Oxaliplatin Radiation Thera... | 16 Years - | M.D. Anderson Cancer Center | |
| Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer | NCT02162641 | Squamous Cell C... | Sentinel lymph ... | 18 Years - | The Christie NHS Foundation Trust | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00003596 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer | NCT00316888 | Anal Cancer | cetuximab cisplatin fluorouracil radiotherapy | 18 Years - | Eastern Cooperative Oncology Group | |
| A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer | NCT02797964 | Advanced Solid ... | SRA737 | 18 Years - | Sierra Oncology LLC - a GSK company | |
| SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas | NCT03894618 | Squamous Cell C... Melanoma Non Small Cell ... Urothelial Carc... Gastric Adenoca... Gastroesophagea... Squamous Cell C... Squamous Cell C... Squamous Cell C... Renal Cell Carc... Hodgkin Lymphom... Diffuse Large B... Mismatch Repair... | SL-279252 | 18 Years - | Shattuck Labs, Inc. | |
| Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas | NCT06236464 | Squamous Cell C... Squamous Cell C... | Multiparameter ... | 18 Years - | National Cancer Institute, Naples | |
| Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | NCT00423293 | Anal Cancer | fluorouracil mitomycin C Intensity-modul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | NCT00068744 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
